e-learning
resources
Milan 2017
Sunday, 10.09.2017
Shared exposures related to interstitial disease and airflow obstruction
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pubmed mining for occupational idiopathic pulmonary fibrosis papers
C. Reynolds (London, United Kingdom)
Source:
International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Session:
Shared exposures related to interstitial disease and airflow obstruction
Session type:
Poster Discussion
Number:
406
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Reynolds (London, United Kingdom). Pubmed mining for occupational idiopathic pulmonary fibrosis papers. 406
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Systematic review of content and quality of idiopathic pulmonary fibrosis review articles
Source: ERJ Open Res, 4 (4) 00156-2018; 10.1183/23120541.00156-2018
Year: 2018
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
Source: Eur Respir J 2015; 46: 1113-1130
Year: 2015
Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 147-151
Year: 2012
Role of antibiotics in exacerbations of chronic obstructive pulmonary disease: a Cochrane review
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
The best ERJ papers in pulmonary vascular diseases
Source: International Congress 2019 – The best of the European Respiratory Journal in 2019
Year: 2019
Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study
Source: Annual Congress 2007 - The air we breathe at home and at work
Year: 2007
Association between FVC and mortality or survival in idiopathic pulmonary fibrosis: a systematic literature review
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Fibrotic interstitial lung diseases and air pollution: a systematic literature review
Source: Eur Respir Rev, 29 (157) 200093; 10.1183/16000617.0093-2020
Year: 2020
The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Evidence-based treatment strategies in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 163-168
Year: 2013
The best papers in the ERJ: paediatric pulmonary diseases
Source: Virtual Congress 2020 – The European Respiratory Journal editor's view: our best papers of last year
Year: 2020
Late-breaking abstract: Pathological analysis of acute exacerbation of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020
Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
Source: Eur Respir J 2015; 46: 795-806
Year: 2015
Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation
Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019
Year: 2020
Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science
Source: Eur Respir J 2016; 47:1615-1617
Year: 2016
Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept